They enable precise manipulation of cellular signaling pathways, gene expression regulation, and enzymatic activity, all of which are essential for understanding disease mechanisms and molecular behavior
This led to improved muscle regeneration and a 70% increase in the peak torque of injured muscles compared to controls
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
Developed at Monash University in Australia, AOD9604 was designed to isolate the lipolytic activity attributed to the C-terminal region of hGH while excluding the growth-promoting and diabetogenic effects associated with the full-length hormone
They do not establish a universal response across species, cell systems, experimental concentrations, or material preparations